SPOTLIGHT -
Dr. Alistar on the Need to Develop Biomarkers in Pancreatic Cancer
Angela Tatiana Alistar, MD, discusses the need to develop biomarkers in pancreatic cancer.
Read More
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)